Jj. Caffrey et al., Expanding coincident signaling by PTEN through its inositol 1,3,4,5,6-pentakisphosphate 3-phosphatase activity, FEBS LETTER, 499(1-2), 2001, pp. 6-10
PTEN, a tumor suppressor among the most commonly mutated proteins in human
cancer, is recognized to be both a protein phosphatase and a phosphatidylin
ositol 3,4,5-trisphosphate (PtdIns(3,4,5)P-3) 3-phosphatase. Previous work
[Maehama and Dixon, J. Biol, Chem. 273 (1998) 13375-13378] has led to a con
sensus that inositol phosphates are not physiologically relevant substrates
for PTEN. In contrast, ne demonstrate that PTEN is an active inositol 1,3,
4,5,6-penta-kisphosphate (Ins(1,3,4,5,6)P-5) 3-phosphatase when expressed a
nd purified from bacteria or HEK cells, Kinetic data indicate Ins(1,3,3,5,6
)P-5 (K-m = 7.1 muM) and PtdIns(3,4,5)P-3 (K-m = 26 muM) compete for PTEN i
n vivo. Transient transfection of HEK cells with PTEN decreased Ins(1,3,4,5
,6)Ps levels. We discuss the physiological significance of these studies in
relation to recent work showing that dephosphorylation of Ins(1,3,4,5,6)P-
5 to inositol 1,4,5,6-tetrakisphosphate is a cell signaling event. (C) 2001
Federation of European Biochemical Societies. Published by Elsevier Scienc
e B.V. All rights reserved.